318 related articles for article (PubMed ID: 31392348)
1. ERCC1-XPF targeting to psoralen-DNA crosslinks depends on XPA and FANCD2.
Sabatella M; Pines A; Slyskova J; Vermeulen W; Lans H
Cell Mol Life Sci; 2020 May; 77(10):2005-2016. PubMed ID: 31392348
[TBL] [Abstract][Full Text] [Related]
2. XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.
Bhagwat N; Olsen AL; Wang AT; Hanada K; Stuckert P; Kanaar R; D'Andrea A; Niedernhofer LJ; McHugh PJ
Mol Cell Biol; 2009 Dec; 29(24):6427-37. PubMed ID: 19805513
[TBL] [Abstract][Full Text] [Related]
3. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells.
Lan L; Hayashi T; Rabeya RM; Nakajima S; Kanno Si; Takao M; Matsunaga T; Yoshino M; Ichikawa M; Riele Ht; Tsuchiya S; Tanaka K; Yasui A
DNA Repair (Amst); 2004 Feb; 3(2):135-43. PubMed ID: 14706347
[TBL] [Abstract][Full Text] [Related]
4. The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.
Orelli B; McClendon TB; Tsodikov OV; Ellenberger T; Niedernhofer LJ; Schärer OD
J Biol Chem; 2010 Feb; 285(6):3705-3712. PubMed ID: 19940136
[TBL] [Abstract][Full Text] [Related]
5. Cryo-EM structures of the XPF-ERCC1 endonuclease reveal how DNA-junction engagement disrupts an auto-inhibited conformation.
Jones M; Beuron F; Borg A; Nans A; Earl CP; Briggs DC; Snijders AP; Bowles M; Morris EP; Linch M; McDonald NQ
Nat Commun; 2020 Feb; 11(1):1120. PubMed ID: 32111838
[TBL] [Abstract][Full Text] [Related]
6. Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs.
Kirschner K; Melton DW
Anticancer Res; 2010 Sep; 30(9):3223-32. PubMed ID: 20944091
[TBL] [Abstract][Full Text] [Related]
7. The ERCC1 and ERCC4 (XPF) genes and gene products.
Manandhar M; Boulware KS; Wood RD
Gene; 2015 Sep; 569(2):153-61. PubMed ID: 26074087
[TBL] [Abstract][Full Text] [Related]
8. Repair protein persistence at DNA lesions characterizes XPF defect with Cockayne syndrome features.
Sabatella M; Theil AF; Ribeiro-Silva C; Slyskova J; Thijssen K; Voskamp C; Lans H; Vermeulen W
Nucleic Acids Res; 2018 Oct; 46(18):9563-9577. PubMed ID: 30165384
[TBL] [Abstract][Full Text] [Related]
9. Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
Ahmad A; Enzlin JH; Bhagwat NR; Wijgers N; Raams A; Appledoorn E; Theil AF; J Hoeijmakers JH; Vermeulen W; J Jaspers NG; Schärer OD; Niedernhofer LJ
PLoS Genet; 2010 Mar; 6(3):e1000871. PubMed ID: 20221251
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles of XPF-ERCC1 and Rad1-Rad10-Saw1 in replication-coupled and uncoupled inter-strand crosslink repair.
Seol JH; Holland C; Li X; Kim C; Li F; Medina-Rivera M; Eichmiller R; Gallardo IF; Finkelstein IJ; Hasty P; Shim EY; Surtees JA; Lee SE
Nat Commun; 2018 May; 9(1):2025. PubMed ID: 29795289
[TBL] [Abstract][Full Text] [Related]
11. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
Gentile F; Tuszynski JA; Barakat KH
J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
[TBL] [Abstract][Full Text] [Related]
12. Multiple DNA binding domains mediate the function of the ERCC1-XPF protein in nucleotide excision repair.
Su Y; Orelli B; Madireddy A; Niedernhofer LJ; Schärer OD
J Biol Chem; 2012 Jun; 287(26):21846-55. PubMed ID: 22547097
[TBL] [Abstract][Full Text] [Related]
13. Differential processing of UV mimetic and interstrand crosslink damage by XPF cell extracts.
Zhang N; Zhang X; Peterson C; Li L; Legerski R
Nucleic Acids Res; 2000 Dec; 28(23):4800-4. PubMed ID: 11095693
[TBL] [Abstract][Full Text] [Related]
14. XPF-ERCC1 acts in Unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4.
Klein Douwel D; Boonen RA; Long DT; Szypowska AA; Räschle M; Walter JC; Knipscheer P
Mol Cell; 2014 May; 54(3):460-71. PubMed ID: 24726325
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.
Arora S; Kothandapani A; Tillison K; Kalman-Maltese V; Patrick SM
DNA Repair (Amst); 2010 Jul; 9(7):745-53. PubMed ID: 20418188
[TBL] [Abstract][Full Text] [Related]
16. The knock-down of ERCC1 but not of XPF causes multinucleation.
Rageul J; Frëmin C; Ezan F; Baffet G; Langouët S
DNA Repair (Amst); 2011 Sep; 10(9):978-90. PubMed ID: 21839691
[TBL] [Abstract][Full Text] [Related]
17. Functional Comparison of XPF Missense Mutations Associated to Multiple DNA Repair Disorders.
Marín M; Ramírez MJ; Carmona MA; Jia N; Ogi T; Bogliolo M; Surrallés J
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30658521
[TBL] [Abstract][Full Text] [Related]
18. XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF.
Lehmann J; Seebode C; Smolorz S; Schubert S; Emmert S
Cell Mol Life Sci; 2017 Jun; 74(11):2081-2094. PubMed ID: 28130555
[TBL] [Abstract][Full Text] [Related]
19. Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
Bergstralh DT; Sekelsky J
Trends Genet; 2008 Feb; 24(2):70-6. PubMed ID: 18192062
[TBL] [Abstract][Full Text] [Related]
20. TGF beta promotes repair of bulky DNA damage through increased ERCC1/XPF and ERCC1/XPA interaction.
Zheng H; Jarvis IWH; Bottai M; Dreij K; Stenius U
Carcinogenesis; 2019 Jun; 40(4):580-591. PubMed ID: 30418489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
